This paper is the second in a series of two reviews which and so we have used them in this paper. Thus RA is a subset of IP. focus on the work of the Norfolk Arthritis Register (NOAR), a register of primary care-based inception
Previous prospective studies investigating predictors of cohort patients with inflammatory polyarthritis (IP) .
outcome in early IP The first paper examined genetic and environmental risk factors for the development of IP and of its subset, Table 1 lists all prospective studies which have included at least 50 patients with early (disease duration <3 yr) rheumatoid arthritis (RA) [91] . This paper summarizes the outcome of those patients recruited in [1990] [1991] [1992] [1993] IP and which have investigated clinical and/or genetic predictors of outcome. Most are from European centres, and followed for 3 yr in terms of remission of synovitis, the development of physical disability and radiological probably because differences in the delivery of health care make it difficult to perform such studies in North erosions. We have also examined prognostic indicators. Most of these results have not been published previously America. Over 75% of these reports used the ACR criteria for RA to select patients for study. and this is the first time we have looked at all three outcomes in the same group of patients. The NOAR An accurate picture of disease outcome in IP is best obtained by recruiting patients soon after symptom data are presented in the context of a detailed review of previous studies of IP and RA.
onset and following them prospectively [68] . The studies listed in Table 1 were all based in hospital clinics, although some tried to recruit patients more widely
Background from the local population [29, 33] or by invitation to attend early arthritis clinics [50, 54] . Compared with The ability to predict disease outcome in patients newly presenting with inflammatory polyarthritis (IP) would community-based studies, hospital-based studies are easier to establish and maintain, and offer greater diabe useful from a variety of perspectives [1] , not least that of the patient. For example, there is mounting gnostic certainty. However, left censorship is a major problem in hospital-based studies, particularly those evidence that, to achieve their maximum potential, disease-modifying anti-rheumatic drugs (DMARDs) that recruit using classification criteria for RA, because they exclude patients with mild disease and who enter should be given as soon as possible after disease onset, before the disease process has become established and remission early. The Norfolk Arthritis Register (NOAR) aims to recruit all patients with a new onset of IP who irreversible damage has occurred [2] [3] [4] [5] [6] [7] [8] [9] . In order to target treatment appropriately and to avoid exposing present to primary care [69] . Details of the referral and assessment procedures were presented in the previous patients with mild disease to potentially toxic drugs, it would be helpful to know which patients with IP are paper in this series [91] . In this paper we examine disease outcome and prelikely to go on to develop severe rheumatoid arthritis (RA).
dictors of prognosis among patients newly presenting with IP/RA, with emphasis on data from patients Many studies are confined to patients who satisfy the 1987 American College of Rheumatology (ACR) classireferred to NOAR. fication criteria for RA [10] . These criteria do not NOAR study population used in this review perform well in identifying patients with early IP who will later develop RA [11] . Nevertheless, they do give Between January 1990 and February 1993, 635 patients were referred to NOAR. Of these, 56 were later excluded some consistency in patient selection between studies because of an alternative diagnosis. Of the remaining 579 patients, 486 (84%) were followed for 3 yr, 24 (4%) and (iii) radiological damage, using the grading system bAccording to 1987 ACR criteria applied in list format.
of Larsen et al. [71] . To aid comparison with previous cAccording to 1987 ACR criteria applied in classification tree format. studies, we also assessed outcome in the subset of 231 patients who satisfied the classification criteria for RA fidence interval (CI ) 0, 18]. There was no association between symptom duration at presentation and future at baseline.
remission.
Remission of synovitis
Functional disability The first systematic approach to the definition of remission in RA was carried out on behalf of the American
We defined 'moderate' functional disability as an HAQ score of 1. Disability scores were highest at baseline, Rheumatism Association (ARA) [72] . To fulfil the ARA criteria for remission, a patient must satisfy at least five with an improvement at 1 yr ( Fig. 1) . A similar pattern has been observed in some previous studies [39, 58] but of the following criteria for at least two consecutive months: morning stiffness lasting ∏ 15 min; no fatigue; not in others [35] . In the NOAR cohort, the median HAQ score was 0.63 after 3 yr in the whole NOAR no joint pain by history; no joint tenderness or pain on motion; no soft tissue swelling in joints or tendon group, and 0.88 in patients classified as having RA. The proportion of patients with a HAQ score 1 was 36% in sheaths; and erythrocyte sedimentation rate (ESR) <30 mm/h for men and <20 mm/h for women.
the whole group and 47% in patients classified as having RA. Similar results are found in most other studies of Although these criteria have been used in other studies, the proportion of patients satisfying them is usually very early RA [30, 58] . In the ERAS study, Young et al. [39] reported that 33% patients had an HAQ score >1 after low and there is still no universally accepted definition of remission [66 ] . We could not use the ARA remission 3 yr. An exception is the study by van der Heijde et al. [46 ] , in which patients were reviewed every 4 weeks and criteria in the NOAR study [66 ] since we did not see patients in two consecutive months and did not measure had a mean HAQ score of only 0.35 at 2 yr. In the NOAR cohort, baseline HAQ scores were the ESR or fatigue. Only 6% of the NOAR patients satisfied the remaining four criteria cross-sectionally at related to the number of swollen joints (Spearman's r, 0.52) and the number of tender joints (Spearman's r, 3 yr, and only 11% satisfied them cross-sectionally at any time point during follow-up. We therefore classified 0.50). There was a linear relationship between age at disease onset and HAQ scores for all years (test for patients as being in 'remission off treatment' (as opposed to being in 'treatment-induced remission') if they had linear trend, P < 0.01). Women had significantly higher HAQ scores at all time points. no soft-tissue joint swelling and had not been treated with DMARDs or steroids within the previous 3 months. The proportion of patients classified as being in remisRadiological damage sion at 1, 2 and 3 yr is shown in Table 3 . Only 55 (11%) patients were in remission at 1, 2 and 3 yr and could be Three hundred and ninety (80%) of the 486 patients in the NOAR study satisfied the study criteria to be classified as having complete resolution of their disease.
These remission rates are similar to those from other X-rayed. X-rays were available for 335 patients. The median time from symptom onset to the latest available studies of IP. Woolf et al. [42] found that 30% of 88 patients with early synovitis were in remission at 5 yr.
X-ray was 22 months. Due to the selection criteria, the 335 patients X-rayed had slightly more severe disease Nissilä et al. [27] reported a remission rate of 38% at 3 yr in 268 patients with definite RA or undifferentiated than the whole NOAR cohort. For example, 207 (61%) satisfied classification criteria for RA at baseline and arthritis. Higher remission rates (54% at a mean of 6.9 yr) were reported in a North American study of 532 38% had a positive test for rheumatoid factor (RF ). One hundred and thirty-seven (41%) of the patients patients classified as having undifferentiated IP when first seen [57] . Patients classified as having RA have X-rayed had developed erosions, with a slightly higher much lower remission rates [27, 33, 57] . In the ERAS study, only 15% patients with a clinical diagnosis of RA were in 'sustained clinical remission' after 3 yr [40] .
We found a significant association between remission and younger age at disease onset: 62% of patients aged 16-25 yr at disease onset were in remission at 3 yr compared with only 30% of patients over 25 yr of age. Remission rates at 3 yr were slightly higher in males (37%) than in females (29%); [8% difference: 95% con- F. 1. Distribution of HAQ scores from baseline to 3 yr (n = 477).
aAccording to 1987 ACR criteria in list format.
prevalence (46%) among those who satisfied classificaStudy design tion the criteria for RA at baseline. The median Larsen Studies of hospital-based RA patients are likely to find score was 3 (range 0-73) in all patients X-rayed, 15 different predictors from studies of primary care-based (range 2-73) in the subset with erosions, and 4 [range patients with IP because factors such as age, gender, 0-73] in those who satisfied the classification criteria social class, psychological status, education, occupation, for RA. The prevalence of erosions was slightly higher disease duration and disease severity influence hospital in men (46%) than in women (39%) (difference of referral. For example, older patients with IP may be 7 percentage units, 95% CI −5, 19). There was a more likely to have persistent disease than younger significant relationship between the development of patients. However, once patients are seen in a hospital erosions and older age at disease onset (test for linear clinic with confirmed RA, age may have no influence trend, P = 0.01). The prevalence of erosions was also on disease severity. Therefore, age may be identified as higher in patients with a longer symptom duration a predictor of erosions in a study based in primary care, before initial presentation (test for linear trend, but not in a hospital clinic. The size of the study is also P = 0.03).
important. Large studies are more likely to yield robust prediction models, assuming that they are conducted Overall disease outcome rigorously, without substantial misclassification and measurement error. The overlap between disease persistence, functional disability and radiological erosions in the NOAR group is Definition of disease outcome illustrated in Fig. 2 . Among the 335 patients X-rayed, 74 (22%) had erosions, persistent synovitis and a HAQ Although most studies have investigated broadly similar score 1, whereas only 44 (13%) had none of these. outcomes, they have used different methods of assessPatients with erosions did not necessarily have high ment. For example, radiological outcome can be measdisability scores, and vice versa. These two outcomes ured as the presence/absence of erosions, an overall may become more closely related in later disease [73] .
score of radiological damage, or the number of eroded joints. In addition, outcome is reported at different times after disease onset.
Predicting disease outcome using clinical
Methods of analysis variables measured at presentation:
Most studies have used multivariate techniques such as methodological issues multiple logistic regression, multiple linear regression and discriminant analysis. These can produce different Many investigators have tried to predict disease outcome results depending on how the independent variables are in IP and RA using clinical variables obtained when the categorized and the rules used to retain/remove variables patient is first seen. Although some consistent predictors from the models. have been identified (principally RF ), the results have differed widely, in terms of both the accuracy of predicValidating the results tion and which factors are associated with an adverse prognosis. The results of studies using multivariate
The statistical significance of a multivariate model can analysis are shown in Table 4 . The reasons for the be reported as a P value, but this is not very informative. differences in study conclusions are complex, and are It is better to assess the ability of the model to identify discussed below.
correctly patients with the outcome using a separate re-test sample. The Middlesex Hospital Study is the only other study to do this [23] [24] [25] [26] . Large numbers of patients are required for this method, and the performance of the model in the re-test sample is invariably less good than in the original sample. Even if a separate re-test sample is used, the model may still not be generalizable to other patient cohorts.
Selection of possible predictors
The results of a multiple logistic regression analysis are dependent on the variables which are included as possible predictors. If the baseline HAQ score is not entered as a possible predictor, then it will not be selected!
Presentation of the results
Most studies have presented their results in terms of the amount of variance explained or the overall accuracy of information for the clinician is the probability that an tive predictive values (PPV and NPV ). The PPV represents the proportion of patients with a positive test (for individual patient, presenting with particular clinical features, will or will not develop the outcome in question.
example RF-positive) who develop the outcome in question, and the NPV represents the proportion of patients This information can be expressed as positive and nega- We have also developed simple algorithms ( Table 6 ) which can be employed easily in clinical practice. This able to cohorts with similar basic characteristics.
was straightforward for erosions, since only two predictors (RF and initial disease duration) were selected.
Predicting outcome in the NOAR population
To predict functional disability, we used recursive partiusing multiple logistic regression tioning [74] to reduce the number of variables in the model from five to two. We used multiple logistic regression techniques to
The clinical usefulness of a prediction model depends identify baseline variables associated with outcome at on the setting in which it is to be employed. In primary 3 yr. Some of the results have been reported previously care, it is important that the model is simple to apply [64-66 ], but not using this particular cohort or with and includes variables which are readily available. If 3 yr of follow-up. The following variables, recorded at such a model is used to decide whether patients should presentation, were entered as possible predictors: (i) be referred to hospital, then high NPVs are more demographic: age at symptom onset (divided by tertiles: important than high PPVs. For example, if patients who 16-46, 47-61, >61), gender, initial disease duration in have a negative test result are not referred to hospital, months (divided by tertiles: 0-3, 4-7, >7); (ii) clinical:
it is important that few of them develop an adverse soft-tissue swelling of the individual joint areas; swelling outcome. However, if prediction models are being used of large joints (elbow, shoulder, knee); individual comto select patients for more aggressive therapy, the PPVs ponents of the 1987 ACR classification criteria (excludneed to be higher in order to give an acceptable ing X-rays); total number of swollen joints (divided by risk:benefit ratio. The results in Table 5 show that, tertiles: 0-4, 5-11, >11); and total number of tender whereas PPVs were relatively low (63 and 61%), NPVs joints (divided by tertiles: 0-5, 6-14, >14); HAQ score 1; and (iii) laboratory: RF-positive 1:40, RF-positive 1:160. Results were adjusted for use of DMARDs/ T 6. Simple algorithms to categorize patients according to probsteroids. Each outcome variable was dichotomized. All ability of (i) erosions; and (ii) HAQ Á1 at 3 yr variables were entered and then removed manually in a Predicting radiological erosions stepwise fashion if they had a P-value of >0.05.
Risk
Initial disease Probability of Prediction models were generated using a random two- erosions (70%). Other studies which attempted to predict were higher (74 and 81%). However, these NPVs may to hospital for occupational reasons. Other intriguing possibilities include different responses to DMARDs in still be too low to be clinically useful. Our data may be used as a guide in management/referral decisions but males and females and different prescribing practices. In the NOAR study, a higher proportion of men had should not be used to replace clinical judgement.
been treated with DMARDs (54%) than women (46%). Mortality studies in RA suggest that two groups, younger men and older women, have a particularly A review of the influence of individual reduced life expectancy. The literature on early RA predictors on disease outcome suggests that, while most young men with RA go into remission, those who do not have a poor outcome.
Demographic variables
Age. The relationship between age and disease outDisease duration at the time of presentation. We found that the duration of symptoms at presentation was an come is complex. The median age of patients referred to NOAR (55 yr) was similar to that reported in recent independent predictor of future disability and radiological damage. Only a few other studies have examined hospital-based studies [33, 40, 46, 54, 58] . This suggests that age per se does not influence referral to hospital.
initial disease duration as a predictor of outcome. Some reported that patients with a longer disease duration did We found that younger patients were more likely to enter 'remission off treatment ' There are a number of possible explanations for the association between disease duration and outcome. rates in younger patients, whereas Eberhardt et al. [33] and Pease et al. [75] did not. We found that older First, patients who present earlier may have self-limiting disease. However, remission rates at 3 yr were not patients were more likely to be disabled according to the HAQ. Although we previously reported that age influenced by the time to presentation. Secondly, patients who have had the disease for longer have had a longer was an independent predictor of moderate disability at 1 yr [64] , in the present analysis it was not selected as time in which to develop, for example, erosions. However, the relationship persisted when, in the multivaan independent predictor of the HAQ at 3 yr. Others have also reported that age is not independently associriate analysis, we entered time from disease onset to X-ray as one of the independent variables. Finally, ated with disability at 1 yr [58], 2 yr [33, 46 ] or 3 yr [39] . However, age has been independently associated patients who present later to medical care may have a worse prognosis. This could be either because delay in with disability at 8 and 16 yr [26, 29] , perhaps because older people without arthritis may have higher HAQ presentation is a confounder for other factors associated with a poor prognosis, such as social class, psychological scores. Finally, we found that older patients were more likely to develop radiological erosions. This is in accordfactors and type of disease, or because patients have missed the opportunity for early treatment with ance with some previous reports [28, 46 ] but not with others [24, 37, 59 ].
DMARDs. Some workers have reported that patients with an insidious disease onset (who are likely to seek In summary, in the NOAR study, older patients had a worse prognosis. In contrast to one other study [76 ] , medical care later than those with an explosive onset) have a worse prognosis [24, 33, 79] . However, this was we found that the prevalence of RF positivity rose with age (test for linear trend, P = 0.04). It may be that age not the case in other studies [12, 29, 30, 80] . We favour the last hypothesis, that the association is due to the was not selected as an independent predictor of outcome in the multivariate analysis because of its association missed opportunity for early DMARD therapy. In the NOAR study, the period of 3 months from symptom with RF.
Gender. Many previous studies reported an adverse onset was selected because we divided disease duration into tertiles, the lowest of which was 3 months. However, prognosis in females, and none reported that outcome is worse in males. In the NOAR cohort, men were more others have also suggested that this period of 3 months is critical [81] . likely to enter remission. This is in accordance with previous reports [32, 40] . Disability scores were higher Clinical variables in women. This may be related to differences in perceived ability between males and females, since van den Ende A large number of clinical variables have been proposed as predictors of outcome ( Table 4) . Some of these are et al. [77] reported that males were more likely to overestimate their functional ability according to the discussed below. Baseline HAQ score. The baseline HAQ score was by HAQ. However, Deighton et al. [78] felt that higher HAQ scores in women were explained entirely by disease far the most important predictor of future disability in NOAR. A logistic regression model including only the severity. Gender had little influence on the development of radiological erosions or the total Larsen score. Only HAQ score (Á1; <1) as an independent predictor was almost as accurate as the model which also included all two previous studies have reported that females have a worse radiological outcome [17, 37] .
other baseline variables. The importance of functional ability at baseline has been reported by other studies There are a number of biological reasons why females may have an adverse prognosis. It is also possible that using multivariate techniques [29, 33, 35, 38, 58] , with one exception [23] . Baseline HAQ was also the most men with milder disease are more likely to be referred [23, 26, 29, 35, 42] . In the NOAR study, we istics within and between countries. identified a positive RF test as being an important
The entry criteria for the NOAR study were deliberpredictor of disease persistence, with a PPV of 93% ately broad in order to avoid left censorship. This means compared with 59% for a negative RF test. Other studies that our results are not necessarily applicable to patients have also noted that seronegative patients are more seen in hospital clinics, although 73% of NOAR patients likely to enter remission.
were also referred to hospital. The proportion of patients with 'true' RA is lower in the NOAR study than in hospital-based studies. We view RA as a subset of IP, Genetic factors or the peak of the IP iceberg rather than viewing 'nonMany studies have investigated genetic predictors, prin-RA' IP as a separate condition. cipally HLA-DRB1 alleles, in prospective studies of early RA. Of seven studies investigating radiological X-ray data erosions in early RA, four report a positive association When the NOAR study was designed, we wanted to [45, 51, 54, 62] and three report no association [36, 56, avoid exposing patients with mild disease, who would 61]. There is also disagreement about the influence of be unlikely to have erosions, to irradiation. However, HLA-DRB1 alleles on functional disability and disease with hindsight, it would have been preferable to request persistence [32, 36, 53, 54, 60, 84] . We performed X-rays for all patients, which we are now doing at 5 yr. detailed typing for HLA-DRB1 alleles using PCR based Sixteen per cent of patients who did not satisfy the methods in 532 patients who were followed up for 2 yr, criteria to have X-rays taken had erosions after 5 yr. A 359 of whom had X-rays taken [67] . In brief, we found second concern is that we have used the results of X-rays that HLA-DRB1 alleles had no influence on the developtaken a median of 22 months after disease onset. A ment of persistent disease and only a moderate influence number of potentially erosive patients may not yet have on the development of functional disability. However, developed radiologically visible changes [87] . The data there was a clear association with the development of presented here, therefore, refer to the prediction of early radiological erosions. Patients with at least one copy of erosions. any shared epitope (SE)-bearing allele were approxiClinical and demographic data analysed mately twice as likely to develop erosions as those who were SE-negative: the relative risk was 1.9 (95% CI 1.4, We did not measure laboratory indices of inflammation, 2.6). Of particular interest, we found that HLA-DRB1 such as C-reactive protein (CRP) and ESR, at baseline. alleles were important only in patients who were
Other studies have suggested that these measures are RF-negative, and did not influence outcome in seroposiimportant predictors of outcome [55, 88, 89] . Although tive patients ( Table 7) . Thus, knowledge of SE status information on social class was not included in the has little additional benefit over that of RF alone in present analysis, the results of a separate analysis suggest identifying patients likely to develop erosions. Our data that social class, measured in a number of ways, does do not support the routine genetic screening of patients not influence the outcome. This is in contrast to some other studies [35, 90] . Data on smoking status, with early IP to identify those at high risk of erosions. In collaboration with other units investigating early 
